简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2017-08-24 14:46 Publication of Clinical Data Demonstrating Low Immunogenicity and Excellent Efficacy of Nuwiq® in Previously Untreated Patients
2017-08-24 09:52 Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform
2017-08-23 10:00 Solid Gold® Holistic Pet Nutrition Fetches International Interest with Chinese Distributor, Global Supply Ecommerce Co., Ltd
2017-08-22 16:18 Anatara and Zoetis to Negotiate Terms of an International Detach® Commercial Agreement
2017-08-22 15:02 Study Investigates Performance of Masimo PVi® As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery
2017-08-21 15:25 Boehringer Ingelheim: Advancing anticoagulation care with new data at ESC Congress 2017
2017-08-15 11:05 Dubai Health Authority Implements Masimo Patient SafetyNet™
2017-08-10 14:27 noUV [Price: 1,800 yen (excluding tax) / Capacity: 10 capsules] & noUV Care White [Price: 9,800 yen (excluding tax) / Capacity: 90 capsules] (Photo: Business Wire)
2017-08-10 13:36 FDA Allows WIN Consortium to Proceed with Targeted Tri-Therapy Clinical Trial in First Line Treatment of Metastatic Non Small Cell Lung Cancer
2017-08-09 10:12 A.M. Best Assigns Credit Ratings to Ping An Health Insurance Company of China, Ltd.
2017-08-08 16:31 Study Evaluates Performance of Masimo SpHb® in Trauma Patients with Low Hemoglobin Levels
2017-08-04 14:14 Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run
2017-08-03 12:29 Graminex L.L.C. Receives NNHPD Health Canada Approval for PollenAid® and Prostanex®
2017-08-03 12:19 Study Compares Performance of Masimo Acoustic Respiration Rate (RRa®) and Nellcor Plethysmographic Respiration Rate in Volunteers
2017-08-01 17:39 FDA's Plan to Lower Nicotine in Cigarettes to Non-Addictive Levels Shines Spotlight on 22nd Century Group
2017-07-31 15:05 Takeda Reports 1st Quarter FY2017 Results
2017-07-28 10:17 Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV
2017-07-28 10:12 Sulzer: Counterfeiters and Patent Infringers at the IDS 2017 – Sulzer Mixpac Continues to Enforce Its Rights
2017-07-28 10:09 Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA®
2017-07-26 11:49 Janssen Announces Phase 3 Pivotal Study Results for Darunavir-Based Complete Treatment Regimen

Business Wire Weibo

Press Releases

Latest Releases